199 related articles for article (PubMed ID: 26822100)
1. Double-masked, randomized, placebo-controlled study to evaluate the efficacy and tolerability of intranasal K305 (3% tetracaine plus 0.05% oxymetazoline) in anesthetizing maxillary teeth.
Hersh EV; Pinto A; Saraghi M; Saleh N; Pulaski L; Gordon SM; Barnes D; Kaplowitz G; Bloom I; Sabti M; Moore PA; Lee S; Meharry M; He DY; Li Y
J Am Dent Assoc; 2016 Apr; 147(4):278-87. PubMed ID: 26822100
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 3 intranasal mists for anesthetizing maxillary teeth in adults: A randomized, double-masked, multicenter phase 3 clinical trial.
Ciancio SG; Marberger AD; Ayoub F; Garlapo DA; Pantera EA; Pantera CT; Al-Mubarak S; Sobieraj BD; He DY; Myneni SR
J Am Dent Assoc; 2016 May; 147(5):339-347.e1. PubMed ID: 26892312
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia.
Ciancio SG; Hutcheson MC; Ayoub F; Pantera EA; Pantera CT; Garlapo DA; Sobieraj BD; Almubarak SA
J Dent Res; 2013 Jul; 92(7 Suppl):43S-8S. PubMed ID: 23690356
[TBL] [Abstract][Full Text] [Related]
4. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Kovanaze) in Maxillary Teeth.
Capetillo J; Drum M; Reader A; Fowler S; Nusstein J; Beck M
J Endod; 2019 Mar; 45(3):257-262. PubMed ID: 30803532
[TBL] [Abstract][Full Text] [Related]
5. Intranasal tetracaine and oxymetazoline: a newly approved drug formulation that provides maxillary dental anesthesia without needles.
Hersh EV; Saraghi M; Moore PA
Curr Med Res Opin; 2016 Nov; 32(11):1919-1925. PubMed ID: 27646144
[TBL] [Abstract][Full Text] [Related]
6. Intranasal tetracaine and oxymetazoline spray for maxillary local anesthesia without injections.
Saraghi M; Hersh EV
Gen Dent; 2017; 65(2):16-19. PubMed ID: 28253176
[No Abstract] [Full Text] [Related]
7. The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings.
Giannakopoulos H; Levin LM; Chou JC; Cacek AT; Hutcheson M; Secreto SA; Moore PA; Hersh EV
J Am Dent Assoc; 2012 Aug; 143(8):872-80. PubMed ID: 22855901
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of an Intranasally Administered Combination of Oxymetazoline and Tetracaine in Healthy Volunteers.
Cacek AT; Gobburu JV; Gopalakrishnan M
J Clin Pharmacol; 2017 Feb; 57(2):247-254. PubMed ID: 27436060
[TBL] [Abstract][Full Text] [Related]
9. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
10. Kovanaze Intranasal Spray vs Traditional Injected Anesthetics: a Study of Pulpal Blood Flow Utilizing Laser Doppler Flowmetry.
Thayer S; Townsend JA; Peters M; Yu Q; Odom M; Sabey KA
Anesth Prog; 2022 Apr; 69(1):31-38. PubMed ID: 35377931
[TBL] [Abstract][Full Text] [Related]
11. Effect of Intranasal Vasoconstrictors on Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled Trial.
Bellew SD; Johnson KL; Nichols MD; Kummer T
J Emerg Med; 2018 Oct; 55(4):455-464. PubMed ID: 30195946
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy of 4% articaine with 1:100,000 epinephrine and 2% lidocaine with 1:80,000 epinephrine in achieving pulpal anesthesia in maxillary teeth with irreversible pulpitis.
Kanaa MD; Whitworth JM; Meechan JG
J Endod; 2012 Mar; 38(3):279-82. PubMed ID: 22341059
[TBL] [Abstract][Full Text] [Related]
13. Intranasal anesthetic effects of lidocaine and tetracaine compared.
Noorily AD; Otto RA; Noorily SH
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):370-4. PubMed ID: 7567006
[TBL] [Abstract][Full Text] [Related]
14. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
[TBL] [Abstract][Full Text] [Related]
15. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
Ferguson BJ; Paramaesvaran S; Rubinstein E
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging.
Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P
Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443
[TBL] [Abstract][Full Text] [Related]
17. Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.
Pitkäranta A; Wecker MT; Korts DC; Hayden FG
Am J Rhinol; 1998; 12(2):125-9. PubMed ID: 9578931
[TBL] [Abstract][Full Text] [Related]
18. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
Druce HM; Ramsey DL; Karnati S; Carr AN
Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
[TBL] [Abstract][Full Text] [Related]
19. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
[TBL] [Abstract][Full Text] [Related]
20. Intranasal topical local anesthetic and decongestant for flexible nasendoscopy in children: a randomized, double-blind, placebo-controlled trial.
Chadha NK; Lam GO; Ludemann JP; Kozak FK
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1301-5. PubMed ID: 24158493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
